
The limits of a 24-hour alteplase window
Late alteplase improves one recovery measure but raises bleeding risk and leaves important timing questions unresolved.
Read briefingDaily Clinical Briefings

Late alteplase improves one recovery measure but raises bleeding risk and leaves important timing questions unresolved.
Read briefing
Promising laboratory findings do not establish safe human use, particularly when injectable product quality is uncertain.
Read briefing
Simulation can help teams rehearse difficult interactions, but reported benefits need careful interpretation.
Read briefing
GRADE helps distinguish promising research findings from evidence reliable enough to guide clinical decisions.
Read briefing
Lifetime lipid exposure, inherited markers and inflammatory disease can change prevention decisions despite reassuring results.
Read briefing
Mentoring, curiosity and personal priorities help clinicians decide which opportunities deserve their time.
Read briefing
Assess deficits, shock and mechanism before deciding how much fluid a patient with crush injury needs.
Read briefing
A functioning short peripheral IV can start vasopressors promptly, provided the site is closely monitored.
Read briefing
Atypical symptoms and absent risk factors do not reliably exclude myocardial infarction.
Read briefing
Minimal tenderness is less reassuring in older adults, so CT should remain readily considered.
Read briefing
Mixed upper and lower motor neuron signs matter more than any single investigation when ALS is suspected.
Read briefing
Open “what” questions can uncover concerns and make clinical reasoning easier to examine.
Read briefingBrowse and listen free in the app. Premium adds learning notes, MCQs, reflections, activity tracking and Excel exports for your CPD or appraisal records.